Clinical Trials

180 enrolled

Phase 2/3 Not yet recruiting

Stomach Neoplasms

NCT05433597 2022-06-27

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

172 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT04370418 2022-02-28

Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients

Phase 2/3 Not yet recruiting

8 enrolled

Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

622 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT04393584 2021-04-13

RusGCG-01

538 enrolled

Gastrointestinal Neoplasms, Stomach Neoplasms

NCT02172976 2020-09-02

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

40 enrolled

Pancreatic Neoplasms

NCT00952029 2020-03-30

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

492 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03992911 2019-06-20

Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma

336 enrolled

Endocrine

Carcinoma, Neuroendocrine

NCT01216644 2019-06-19

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

716 enrolled

Pathologic Complete Response, Stomach Neoplasms

NCT02527772 2019-06-04

LD-FOX4/HCC

Phase 2/3 Withdrawn

Carcinoma, Hepatocellular

NCT02534337 2019-06-04

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Carcinoma, Hepatocellular

NCT00647530 2019-05-17

FOxTROT

1,053 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT02220088 2019-01-11

The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial

Phase 2/3 Terminated

79 enrolled

Carcinoma, Hepatocellular

NCT03349177 2017-11-21

Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy

200 enrolled

Breast

Breast Neoplasms

NCT02767375 2017-08-10

HAICAT

192 enrolled

Carcinoma, Hepatocellular

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Phase 2/3 Terminated

4 enrolled

Esophageal Neoplasms

NCT01523431 2017-03-30

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

583 enrolled

Diarrhea, Neutropenia, Colorectal Neoplasms

NCT01204437 2016-02-10

ICE-II

400 enrolled

Breast

Breast Neoplasms

NCT00861094 2015-12-18

Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer

266 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02529774 2015-08-20

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

432 enrolled

Resected Liver Metastases From Colorectal Cancer

NCT01211210 2015-05-22

FOWARC

495 enrolled

Rectal Neoplasms

NCT01829178 2015-05-13

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

30 enrolled

Gastrointestinal Neoplasms

NCT02415699 2015-04-14

DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer

100 enrolled

Colorectal Neoplasms

NCT00785421 2015-01-08

PROSPECT

312 enrolled

Pancreatic Neoplasms

NCT01523015 2013-02-05

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

100 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT00960284 2012-01-13

PACT-7

102 enrolled